Olmutinib
10mM in DMSO
- Product Code: 221271
CAS:
1353550-13-6
| Molecular Weight: | 486.59 g./mol | Molecular Formula: | C₂₆H₂₆N₆O₂S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD29918158 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used in the treatment of non-small cell lung cancer (NSCLC), particularly for patients with EGFR T790M mutation who have progressed after prior EGFR-targeted therapy. It acts as a third-generation EGFR tyrosine kinase inhibitor, selectively targeting resistant mutant forms of EGFR while sparing wild-type EGFR, thereby reducing side effects. Its oral formulation allows for convenient outpatient treatment, contributing to improved patient compliance and disease management.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | $245.46 |
+
-
|
Olmutinib
Used in the treatment of non-small cell lung cancer (NSCLC), particularly for patients with EGFR T790M mutation who have progressed after prior EGFR-targeted therapy. It acts as a third-generation EGFR tyrosine kinase inhibitor, selectively targeting resistant mutant forms of EGFR while sparing wild-type EGFR, thereby reducing side effects. Its oral formulation allows for convenient outpatient treatment, contributing to improved patient compliance and disease management.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :